
Rashi Goswami
About Rashi Goswami
Data last updated:
Rashi Goswami is a Director at Saltvae Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. Saltvae Pharmaceuticals Private Limited reported revenue of ₹2.97 Cr (FY 2024). Earlier, Rashi Goswami was a Director at Extimus Healthcare Private Limited (2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2021 | 2021 | ₹2.97 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jan 2018 | 2018 | ₹1.25 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rashi Goswami
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chander Prakash Goswami | 08018766 | Saltvae Pharmaceuticals Private Limited | Director |
| Harnand Tyagi | 00159923 | Saltvae Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rashi Goswami
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rashi Goswami
Rashi Goswami currently holds 1 directorship: Saltvae Pharmaceuticals Private Limited (Director, since 16 Mar 2021, revenue ₹2.97 Cr (FY 2024)).
Rashi Goswami was first appointed on 18 Jan 2018 as Director at Extimus Healthcare Private Limited. The most recent appointment on record is 16 Mar 2021 at Saltvae Pharmaceuticals Private Limited.
Rashi Goswami held 1 earlier board appointment: Extimus Healthcare Private Limited (Director, 18 Jan 2018 to 26 Sep 2018).
The current boards of Rashi Goswami's companies include Chander Prakash Goswami (Saltvae Pharmaceuticals Private Limited), Harnand Tyagi (Saltvae Pharmaceuticals Private Limited).